You have 1 action to finish to complete your account. Customize your experience by selecting your interests on the Personalization page
No matches

28 search results for: neuroimmune mechanisms

<b>Neuroimmune</b> Axis in Atopic Dermatitis
expert video

Neuroimmune Axis in Atopic Dermatitis

Dermatology
A review of the neuroimmune mechanisms and changes to skin barrier that result in itch in AD.
View more
<b>Neuroimmune</b> Axis and Neuroinflammation in PN
expert video

Neuroimmune Axis and Neuroinflammation in PN

Dermatology
A review of the neuroimmune mechanisms and changes to the dermis that result in itch in PN.
View more
Mast Cells and the <b>Neuroimmune</b> Axis in CSU
expert video

Mast Cells and the Neuroimmune Axis in CSU

Dermatology
A review of the neuroimmune mechanisms and activation of mast cells that result in itch in CSU.
View more
Itch: <b>Neuroimmune</b> Axis in Chronic Pruritic Skin Diseases
expert video

Itch: Neuroimmune Axis in Chronic Pruritic Skin Diseases

Dermatology
A review of the neuroimmune axis and the mechanisms involved in perpetuating chronic itch in AD, PN, and CSU.
View more
Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​
expert video

Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​

Dermatology
A review of the shared and unique neuroimmune mechanisms in the generation of itch across AD, PN, and CSU.
View more
Inside Atopic Dermatitis: Type 2 Inflammation Underlies Skin Barrier and <b>Neuroimmune</b> Dysfunction
expert video

Inside Atopic Dermatitis: Type 2 Inflammation Underlies Skin Barrier and Neuroimmune Dysfunction

Dermatology
Insights from the ESDR 2022 ADVENT symposium, uncovering the role of type 2 inflammation in skin barrier and neuroimmune dysfunction in atopic dermatitis.
View more
The <b>Neuroimmune</b> Axis and Neuroinflammatory Mechanism of Pruritus
expert video

The Neuroimmune Axis and Neuroinflammatory Mechanism of Pruritus

Dermatology
Insights from ESDR 2022 ADVENT symposium, examining the complex mechanisms that underlie pruritus in atopic dermatitis.
View more
Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​ - Panel Discussion
expert video

Itch: The Common Thread in Dermatological Type 2 Inflammation (AD, PN, and CSU)​ - Panel Discussion

Dermatology
Panel discussion exploring how itch differs across AD, PN, and CSU, and how it affects pediatric patients with AD.
View more
Type 2 Inflammation at the <b>Neuroimmune</b> Axis in PN and CSU
expert video

Type 2 Inflammation at the Neuroimmune Axis in PN and CSU

Dermatology
Dr. Elmariah discusses and illustrates the overlapping and distinct roles of type 2 cytokines at the neuroimmune axis in PN and CSU
View more
ADVENT Forum 2022 | Type 2 Inflammation Underlies the Pathophysiology of Multiple Diseases
expert video

ADVENT Forum 2022 | Type 2 Inflammation Underlies the Pathophysiology of Multiple Diseases

Type 2 Inflammation
Dr. Amy Paller and Profs. Alberto Papi, Wytske Fokkens, and Arjan Bredenoord outline the disease-specific mechanisms of type 2 inflammation in the skin, lungs, nasal passage, and esophagus
View more
<b>Mechanisms</b> of Pruritus in AD & PN: Role of Type 2 Inflammation video
expert video

Mechanisms of Pruritus in AD & PN: Role of Type 2 Inflammation video

Dermatology
Neuroimmune mechanisms of chronic pruritus in atopic dermatitis and prurigo nodularis – Clip from the ADVENT symposium at AAD 2023.
View more
Skin Barrier, <b>Neuroimmune</b> Axis, and Type 2 Inflammation in Atopic Dermatitis
expert video

Skin Barrier, Neuroimmune Axis, and Type 2 Inflammation in Atopic Dermatitis

Dermatology
Presentations from the ADVENT symposium at the ISID 2023 meeting on the skin barrier, neuroimmune axis, and type 2 inflammation in atopic dermatitis.
View more

ADVENT is a global medical education non-promotional program by Sanofi and Regeneron. This website is intended only for duly authenticated healthcare professionals in Algeria, Argentina, Australia, Austria, Bahrain, Belgium, Brazil, Bulgaria, Canada, Chile, China, Colombia, Costa Rica, Croatia, Czech Republic, Denmark, Dominican Republic, Ecuador, Egypt, Estonia, Finland, France, Germany, Greece, Guatemala, Hong Kong, Hungary, Iceland, India, Israel, Italy, Japan, Kuwait, Latvia, Lebanon, Lithuania, Macau, Malaysia, Norway, Oman, Panama, Peru, Poland, Portugal, Qatar, Romania, Saudi Arabia, Singapore, Slovenia, South Africa, South Korea, Spain, Sudan, Sweden, Switzerland, Taiwan, Thailand, The Netherlands, Turkey, United Arab Emirates, or the United States of America.

Sanofi | Regeneron Logo

© 2024 Sanofi and Regeneron Pharmaceuticals, Inc.

All rights reserved.
MAT-GLB-2302957 v3.0 11/2023

All Rights Reserved.

Sanofi and Regeneron are global leaders in pharmaceutical development, each with a long history of supporting frontline physicians to improve human health and reduce the burden of disease. Driven by the same commitment to patients and their families, Sanofi and Regeneron have partnered to take on type 2 inflammation and the range of chronic conditions in which excessive inflammation plays a role.

Country/region: ArgentinaChange country/region